Pharmacy

Announcements

Request for Input: 2022 Revisions to USP

The Advisory Pharmacy Compounding Education Committee (APCEC) is working on recommendations
for adopting the 2022 revisions to USP <797>, USP <795>, and USP <800> into Utah State Regulation.
The Committee is requesting input about how to best adopt these new recommendations.

For more information, please refer to this document: USP Update Letter

Elimination of DATA-Waiver Program

A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder. For more information about the elimination of the DATA-Waiver requirement, please refer to this document: DOPL Notice of Elimination of DATA-Waiver Program

DOPL Temporarily Suspends Enforcement of e-Prescribing Requirement for Controlled Substances

See Pharmacy E-Prescribing Law Delay Notice effective 01/01/2022

Electronic Prescriptions for Controlled Substances

Beginning January 1, 2022, Utah Code Annotated 58-37-22 requires that most* prescriptions issued for a controlled substance be transmitted electronically as an electronic prescription; however, you may apply for a limited extension by submitting the form linked below.

Electronic Prescriptions for Controlled Substances: Request for Limited Extension to Comply

^{*FOR INFORMATION ON EXEMPTIONS, PLEASE SEE UTAH CODE ANNOTATED 58-37-22.}

While a prescriber is permitted to use any vendor, the Division* is aware of the vendors identified on the list below.

Electronic Prescribing Vendors

^{*THE DIVISION DOES NOT ENDORSE ANY PARTICULAR VENDOR, AND THE INFORMATION ON THIS RESOURCE SHEET MAY CHANGE AT ANY TIME.}